Screener
Nuvation Bio NUVB Short-Term Investments
Short-Term Investments at other companies
Other financials
Where this comes from
Reported directly by Nuvation Bio in its filing.
Tagged under the XBRL concept us-gaap:MarketableSecuritiesCurrent.
The source filing: Nuvation Bio’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 6:55 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-336646
| Line item | June 30, 2026 | December 31, 2025 |
|---|---|---|
| Accounts receivable, net of allowance for credit loss of $nil and $nil | 27,826 | 16,076 |
| Inventory | 19,901 | 11,411 |
| Prepaid expenses and other current assets | 13,861 | 11,536 |
| Marketable securities | 402,352 | 365,125 |
| Interest receivable on marketable securities | 3,888 | 3,285 |
| Total current assets | 726,432 | 571,519 |
| Property and equipment, net of accumulated depreciation of $1,331 and $1,184, respectively | 715 | 564 |
| Intangible assets, net of accumulated amortization of $2,777 and $1,856, respectively | 10,292 | 11,214 |
Item 1. Financial Statements.
FAQ
- What is Nuvation Bio's short-term investments?
- Nuvation Bio (NUVB) reported short-term investments of $402.35M in Q2 2026.
- How has Nuvation Bio's short-term investments changed year-over-year?
- Nuvation Bio's short-term investments increased by 11.8% year-over-year, from $359.75M to $402.35M.
- What is the long-term trend for Nuvation Bio's short-term investments?
- Over 5 years (2020 to 2025), Nuvation Bio's short-term investments has grown at a 14.4% compound annual growth rate (CAGR), from $186M to $365.13M.
- What does short-term investments mean?
- Marketable securities and other investments with maturities between three months and one year, providing yield above cash while maintaining liquidity.
Ask your AI about Nuvation Bio's short-term investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude